ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,419.83
-0.26%
US Tech 100
19,105.20
0.19%
다우존스 지수
38,542.00
-0.27%
Bitcoin
65,787.47
-1.46%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. VYNE Therapeutics Inc (VYNE)

  7. VYNE Therapeutics Inc (VYNE) 뉴스

VYNE

VYNE Therapeutics (VYNE)

VYNE Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VYNE
일자시간출처헤드라인심볼기업
2024/06/0505:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/05/1005:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYNEVYNE Therapeutics Inc
2024/05/0921:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
2024/03/0207:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VYNEVYNE Therapeutics Inc
2024/03/0207:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYNEVYNE Therapeutics Inc
2024/02/2922:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
2024/02/0223:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0407:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0407:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0407:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0407:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0407:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0407:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0407:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2024/01/0322:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/1607:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/1607:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/1607:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/1607:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/1607:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/1406:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/1406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
2023/12/0506:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
2023/11/2414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VYNEVYNE Therapeutics Inc
2023/11/2306:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VYNEVYNE Therapeutics Inc
2023/11/1706:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VYNEVYNE Therapeutics Inc
2023/11/1406:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VYNEVYNE Therapeutics Inc
2023/11/1406:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VYNEVYNE Therapeutics Inc
2023/11/1406:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VYNEVYNE Therapeutics Inc
2023/11/1405:59Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VYNEVYNE Therapeutics Inc
 검색 관련기사 보기:NASDAQ:VYNE

최근 히스토리

NYSE
VZ
Verizon Communications
FX
USDEUR
US Dollar vs Euro
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
KO
Coca Cola
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
FX
USDJPY
US Dollar vs Yen
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
NYSE
CVX
Chevron
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
COIN
SOLUSD
Solana
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유